全文获取类型
收费全文 | 6845篇 |
免费 | 288篇 |
国内免费 | 50篇 |
专业分类
耳鼻咽喉 | 30篇 |
儿科学 | 114篇 |
妇产科学 | 72篇 |
基础医学 | 876篇 |
口腔科学 | 251篇 |
临床医学 | 416篇 |
内科学 | 1906篇 |
皮肤病学 | 59篇 |
神经病学 | 448篇 |
特种医学 | 237篇 |
外科学 | 1326篇 |
综合类 | 28篇 |
预防医学 | 144篇 |
眼科学 | 234篇 |
药学 | 351篇 |
中国医学 | 8篇 |
肿瘤学 | 683篇 |
出版年
2023年 | 30篇 |
2021年 | 125篇 |
2020年 | 65篇 |
2019年 | 104篇 |
2018年 | 121篇 |
2017年 | 91篇 |
2016年 | 135篇 |
2015年 | 129篇 |
2014年 | 184篇 |
2013年 | 224篇 |
2012年 | 392篇 |
2011年 | 408篇 |
2010年 | 199篇 |
2009年 | 185篇 |
2008年 | 349篇 |
2007年 | 401篇 |
2006年 | 369篇 |
2005年 | 387篇 |
2004年 | 396篇 |
2003年 | 383篇 |
2002年 | 385篇 |
2001年 | 156篇 |
2000年 | 165篇 |
1999年 | 162篇 |
1998年 | 73篇 |
1997年 | 77篇 |
1996年 | 76篇 |
1995年 | 69篇 |
1994年 | 71篇 |
1993年 | 75篇 |
1992年 | 112篇 |
1991年 | 110篇 |
1990年 | 80篇 |
1989年 | 92篇 |
1988年 | 63篇 |
1987年 | 65篇 |
1986年 | 74篇 |
1985年 | 57篇 |
1984年 | 59篇 |
1983年 | 63篇 |
1982年 | 39篇 |
1981年 | 33篇 |
1980年 | 31篇 |
1979年 | 40篇 |
1978年 | 33篇 |
1977年 | 20篇 |
1974年 | 23篇 |
1970年 | 23篇 |
1969年 | 21篇 |
1968年 | 21篇 |
排序方式: 共有7183条查询结果,搜索用时 265 毫秒
1.
Tetsuji Terazawa Takeshi Kato Masahiro Goto Katsuya Ohta Shingo Noura Hironaga Satake Yoshinori Kagawa Hisato Kawakami Hiroko Hasegawa Kazuhiro Yanagihara Tatsushi Shingai Ken Nakata Masahito Kotaka Masayuki Hiraki Ken Konishi Shiro Nakae Daisuke Sakai Yukinori Kurokawa Toshio Shimokawa Taroh Satoh 《The oncologist》2021,26(1):17-e47
Lessons Learned
- Panitumumab monotherapy showed favorable efficacy and feasibility in the treatment of frail or elderly patients with RAS wild‐type unresectable colorectal cancer.
- It is especially effective for left‐sided tumors; therefore, panitumumab as first‐line treatment could be an additional therapeutic option for frail elderly patients, particularly in those who are unsuitable for upfront oxaliplatin‐based or irinotecan‐based combination regimens.
2.
<正>Stroke is a leading cause of mortality and severe neurological disability worldwide; however, curative therapeutic options are limited. Although recanalization therapy using endovascular thrombectomy has demonstrated great benefits in the functional outcome of patients with acute ischemic stroke, the rate of excellent clinical outcomes remains limited. Therefore, the current recanalization 相似文献
3.
Yusuke Kagawa Hiromi Furuta Takehiro Uemura Naohiro Watanabe Junichi Shimizu Yoshitsugu Horio Hiroaki Kuroda Yoshitaka Inaba Takeshi Kodaira Katsuhiro Masago Shiro Fujita Akio Niimi Toyoaki Hida 《Cancer science》2020,111(12):4442
Immune checkpoint inhibitors (ICIs) have dramatically changed the strategy used to treat patients with non‐small‐cell lung cancer (NSCLC); however, the vast majority of patients eventually develop progressive disease (PD) and acquire resistance to ICIs. Some patients experience oligoprogressive disease. Few retrospective studies have evaluated clinical efficacy in patients with oligometastatic progression who received local therapy after ICI treatment. We conducted a retrospective analysis of advanced NSCLC patients who received PD‐1 inhibitor monotherapy with nivolumab or pembrolizumab to evaluate the effects of ICIs on the patterns of progression and the efficacy of local therapy for oligoprogressive disease. Of the 307 patients treated with ICIs, 148 were evaluated in our study; 42 were treated with pembrolizumab, and 106 were treated with nivolumab. Thirty‐eight patients showed oligoprogression. Male sex, a lack of driver mutations, and smoking history were significantly correlated with the risk of oligoprogression. Primary lesions were most frequently detected at oligoprogression sites (15 patients), and 6 patients experienced abdominal lymph node (LN) oligoprogression. Four patients showed evidence of new abdominal LN oligometastases. There was no significant difference in overall survival (OS) between the local therapy group and the switch therapy group (reached vs. not reached, P = .456). We summarized clinical data on the response of oligoprogressive NSCLC to ICI therapy. The results may help to elucidate the causes of ICI resistance and indicate that the use of local therapy as the initial treatment in this setting is feasible treatment option. 相似文献
4.
Liping Lin Megumi Suda Chenlan Xu Yuehan Zhang Yukie Yanagiba Jisheng Nie Tamie Nakajima Zuquan Weng Rui-Sheng Wang 《Journal of applied toxicology : JAT》2020,40(7):979-990
Owing to the use of ethyl tert-butyl ether (ETBE) as a fuel additive, the possible adverse effects of ETBE exposure have become a public concern. Our previous study showed that ETBE-induced toxicity in aldehyde dehydrogenase 2 (Aldh2) gene knockout (KO) mice was caused by its primary metabolite acetaldehyde, which was toxic. However, it is unclear whether tert-butyl alcohol (TBA), another main metabolite of ETBE, plays a role in ETBE-induced toxicity. To investigate this relationship, we analyzed the changes of TBA concentrations in tissues after ETBE exposure, and then evaluated the toxicity after direct TBA treatment in both KO and wild-type (WT) mice. An exposure to 500 ppm ETBE via inhalation resulted in the formation of its three metabolites, TBA, 2-methyl-1,2-propanediol and ethanol, whose concentrations in the liver, brain, fat and testis of male KO mice were significantly higher than the corresponding concentrations observed in male WT mice. Direct treatment to TBA (20 mg/mL of drinking water) caused significant changes in relative organ weights and histopathology, and increased levels of genetic damages in both types of mice. These toxic effects were also seen in KO mice exposed to a lower concentration of TBA (5 mg/mL), which was associated with increased oxidative stress in serum (reduced glutathione and reduced glutathione/oxidized glutathione ratio decreased). Our findings indicate that ALDH2 is involved in the metabolism of ETBE and TBA, and ALDH2 deficiency could greatly increase the sensitivity to TBA-induced toxicity. 相似文献
5.
6.
7.
Hirokazu Miki Shingen Nakamura Masahiro Oura Hirofumi Hamano Kenji Ikuta Naoto Okada Yasunobu Okamoto Kimiko Sogabe Mamiko Takahashi Masami Iwasa Kengo Udaka Takeshi Harada Kiyoe Kurahashi Shiro Fujii Sumiko Yoshida Kumiko Kagawa Itsuro Endo Ken-ichi Aihara Masahiro Abe 《British journal of haematology》2019,186(2):355-358
8.
Ryuichi Iwakiri Kiyohito Tanaka Takuji Gotoda Shiro Oka Takao Ohtsuka Yasuhisa Sakata Toshimi Chiba Kazuhide Higuchi Hironori Masuyama Ryoichi Nozaki Koji Matsuda Nobuyuki Shimono Kazuma Fujimoto Hisao Tajiri 《Digestive endoscopy》2019,31(5):477-497
As part of the activities toward standardizing endoscopy procedures, the Japan Gastroenterological Endoscopy Society has prepared guidelines for cleansing and disinfection of gastrointestinal endoscopes. The environment of gastrointestinal endoscopy differs between Japan and advanced Western countries. In advanced Western countries, gastrointestinal endoscopy is performed almost exclusively at specialized facilities, where strict provisions are observed for cleansing and disinfecting endoscopes. In Japan, however, gastrointestinal endoscopy is performed even in small clinics, and the annual number of gastrointestinal endoscopy cases is enormous. In addition, the method for cleansing and disinfecting endoscopes differs among hospitals. Although there is a distinct lack of evidence for how gastrointestinal endoscopes are cleaned and disinfected, it is necessary to standardize the method for doing so to advance the field of endoscopic medicine. 相似文献
9.
10.
Thomas Ruffing Tilmann Rückauer Frederic Bludau Alexander Hofmann Markus Muhm Arnold J Suda 《Injury》2019,50(2):607-612